Akums Drugs & Pharmaceuticals were recognised for their outstanding supply chain in the healthcare sector at CargoNXT 2025.
Akums Drugs & Pharmaceuticals has been recognised the prestigious ‘Supply Chain Excellence in Healthcare’ at the CargoNXT Recognitions, held on April 25th, 2025, at The Orchid Hotel, Vile Parle, Mumbai. This recognition underscores Akums’ dedication to excellence in the pharmaceutical industry, particularly in the field of healthcare supply chain management.
The recognitions ceremony was attended by prominent figures from the business world, alongside industry leaders from notable companies, including Cipla, Jindal Steel, Storia, Reliance Industries, Mondelez International, Adani Airports, TATA Steel, Aditya Birla, Century Ply, Etihad Air, DBS, Shriram Finance, Sugar Cosmetics, and Continental Carriers.
Akums’ success in the pharmaceutical sector, particularly its strength in exports, global reach, and commitment to continuous innovation, played a significant role in its recognition for Supply Chain Excellence in the Healthcare domain. The recognition highlights the company’s ability to ensure efficient and seamless delivery of essential pharmaceutical products across numerous countries.
The recognition was presented to Team Akums by Shri Deepak Shetty, IRS, Director General of Shipping, Ministry of Shipping, and Shri Nilank Kumar, IRS, Commissioner of Customs, Mumbai. The recognition was a proud moment for Akums, reinforcing its position as a leader in the global pharmaceutical market.
Shri Sandeep Jain, Founder & Managing Director of Akums expressed – “We are honoured and delighted to receive this recognition. This award is a testament to our team’s relentless dedication, innovative approach, and continuous efforts to ensure the timely delivery of high-quality pharmaceuticals products worldwide. We will continue to build on our success, pushing boundaries in both pharma supply chain management and pharmaceutical innovations.”
Akums Drugs & Pharmaceuticals is known for its commitment to excellence in manufacturing and delivering affordable, quality medicines globally. This recognition marks yet another significant milestone in the company’s ongoing journey toward healthcare advancement.
About Akums Drugs & Pharmaceuticals Limited:
Akums is the largest India focused CDMO and a leader in pharmaceutical manufacturing, dedicated to providing high-quality medicines at affordable prices. With a strong focus on innovation, sustainability, and social responsibility, Akums is committed to improving global health and creating a more sustainable future.
Operating across 7 Indian states, Akums runs 15 manufacturing facilities and 5 R&D units, where over 400 scientists work tirelessly to drive innovation and enhance patient care. The company employs more than 16,000 people, and its turnover for FY2024-25 is INR 4,212 crores.
In line with its sustainability goals, Akums planted over 5,000 trees in 2024, with a target of planting 10,000 more in 2025. The company is also focused on promoting native tree plantations, preserving indigenous flora and fauna, and supporting the Clean Ganga Mission to combat plastic pollution.
With these initiatives, Akums continues to lead the way in sustainability and foster a culture of environmental responsibility within its workforce.
